These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31720559)

  • 21. Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors.
    Aoki S; Nakase K; Hayashi N; Nakaminami H; Noguchi N
    J Dermatol; 2021 Sep; 48(9):1365-1371. PubMed ID: 33998707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's new in the management of acne vulgaris.
    Kircik LH
    Cutis; 2019 Jul; 104(1):48-52. PubMed ID: 31487336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARTICLE: A Novel Antibiotic Just for Acne.
    Kircik LH
    J Drugs Dermatol; 2020 Nov; 19(11):s5. PubMed ID: 33196745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study.
    Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N
    J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acne vulgaris: a review of antibiotic therapy.
    Tan AW; Tan HH
    Expert Opin Pharmacother; 2005 Mar; 6(3):409-18. PubMed ID: 15794732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Development of Third-Generation Tetracycline Antibiotics and New Perspectives.
    Rusu A; Buta EL
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for the management of acne vulgaris in adolescents.
    Goulden V
    Paediatr Drugs; 2003; 5(5):301-13. PubMed ID: 12716217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome.
    Batool Z; Lomakin IB; Polikanov YS; Bunick CG
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20530-20537. PubMed ID: 32817463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris.
    Oprica C; Emtestam L; Hagströmer L; Nord CE
    Acta Derm Venereol; 2007; 87(3):246-54. PubMed ID: 17533492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
    Kinney MA; Yentzer BA; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic antibiotic therapy of acne vulgaris.
    Ochsendorf F
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials.
    Moore AY; Hurley K; Moore SA
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V; Legallou F; Richet H; Dreno B
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.